Literature DB >> 24634688

[Not Available].

Mark Hull1, Pierre Giguère2, Marina Klein3, Stephen Shafran4, Alice Tseng5, Pierre Côté6, Marc Poliquin7, Curtis Cooper8.   

Abstract

Year:  2014        PMID： 24634688      PMCID： PMC3950988          DOI： 10.1155/2014/921314

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  168 in total

1.  Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007.

Authors:  C Vellozzi; K Buchacz; R Baker; P R Spradling; J Richardson; A Moorman; E Tedaldi; M Durham; J Ward; J T Brooks
Journal:  J Viral Hepat       Date:  2011-05       Impact factor: 3.728

2.  Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion.

Authors:  M Beld; M Penning; M van Putten; A van den Hoek; M Damen; M R Klein; J Goudsmit
Journal:  Blood       Date:  1999-08-15       Impact factor: 22.113

3.  Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.

Authors:  Alice Tseng; Michelle Foisy
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

4.  Pegylated interferon alpha-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients.

Authors:  Esther Voigt; Christian Schulz; Gerd Klausen; Joerg Goelz; Stefan Mauss; Guenther Schmutz; Heiko Jessen; Lutwin Weitner; Antonius Mutz; Dietmar Schranz; Juergen K Rockstroh
Journal:  J Infect       Date:  2005-11-02       Impact factor: 6.072

5.  Liver transplantation in HCV/HIV positive patients.

Authors:  Yasuhiko Sugawara; Sumihito Tamura; Norihiro Kokudo
Journal:  World J Gastrointest Surg       Date:  2011-02-27

6.  Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.

Authors:  Gregory D Kirk; Jacquie Astemborski; Shruti H Mehta; Chuck Spoler; Cedric Fisher; Danisha Allen; Yvonne Higgins; Richard D Moore; Nezem Afdhal; Michael Torbenson; Mark Sulkowski; David L Thomas
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

7.  Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.

Authors:  Edwin DeJesus; Jürgen K Rockstroh; Keith Henry; Jean-Michel Molina; Joseph Gathe; Srinivasan Ramanathan; Xuelian Wei; Kitty Yale; Javier Szwarcberg; Kirsten White; Andrew K Cheng; Brian P Kearney
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

8.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

9.  Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany.

Authors:  E Anadol; S Beckebaum; K Radecke; A Paul; A Zoufaly; M Bickel; F Hitzenbichler; T Ganten; J Kittner; M Stoll; C Berg; S Manekeller; J C Kalff; T Sauerbruch; J K Rockstroh; U Spengler
Journal:  AIDS Res Treat       Date:  2012-07-30

10.  The effects of boceprevir and telaprevir on the pharmacokinetics of maraviroc: an open-label, fixed-sequence study in healthy volunteers.

Authors:  Manoli Vourvahis; Anna Plotka; Constantino Kantaridis; Annie Fang; Jayvant Heera
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.